The Valley Desk

NCT01604850 · Interventional trial

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Overall registry status Completed

Phase 3

Conditions Chronic Hepatitis C

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov